Chris Asquith
banner
chrisasquith.bsky.social
Chris Asquith
@chrisasquith.bsky.social
Medicinal Chemistry PI at @uef_farmasia @uniuef.bsky.social
Hitting the target! Here is our recent review in Euro J Med Chem highlighting the uses and advantages of the very versatile Dimroth Rearrangement in both drug discovery and process chemistry.
@uniuef.bsky.social, @elsevierconnect.bsky.social, #chemsky - Check it out - doi.org/10.1016/j.ej...
March 5, 2025 at 10:59 AM
Here is our new publication reviewing medicinal chemistry applications of the Dimroth Rearrangement in drug discovery. - check it out in Euro J Med Chem - doi.org/10.1016/j.ej...
Redirecting
doi.org
February 19, 2025 at 10:12 AM
Reposted by Chris Asquith
A new paper reports the engineering of small-molecule ligands that covalently attach to their cognate RNA aptamers in vitro and in living cells

www.nature.com/articles/s41...
Engineering covalent small molecule–RNA complexes in living cells - Nature Chemical Biology
Small-molecule ligands have been developed that covalently attach to their cognate RNA aptamers in vitro and in living cells. This strategy opens up new avenues for RNA imaging applications (for examp...
www.nature.com
January 10, 2025 at 3:08 PM
Reposted by Chris Asquith
Interesting design of new ebola/marburg virus inhibitors pubs.acs.org/doi/10.1021/...
Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg Viruses
Ebola and Marburg (EBOV and MARV) filoviral infections lead to fatal hemorrhagic fevers and have caused over 30 outbreaks in the last 50 years. Currently, there are no FDA-approved small molecule therapeutics for effectively treating filoviral diseases. To address this unmet medical need, we have conducted a systematic structural optimization of an early lead compound, N-(4-(4-methylpiperidin-1-yl)-3-(trifluoromethyl)phenyl)-4-(morpholinomethyl)benzamide (1), borne from our previously reported hit-to-lead effort. This secondary round of structure–activity relationship (SAR) involved the design and synthesis of several deconstructed and reconstructed analogs of compound 1, which were then tested against pseudotyped EBOV and MARV. The antiviral activities of the most promising leads were further validated in infectious assays. The optimized analogs exhibited desirable antiviral activity against different ebolaviruses and reduced off-target activity. Additionally, they also possessed druglike properties, that make them ideal candidates for in vivo efficacy studies as part of our ongoing drug discovery campaign against EBOV and MARV.
pubs.acs.org
December 19, 2024 at 7:41 AM
Reposted by Chris Asquith
The docking of a 1.7 billion- vs a 99 million-molecule virtual library against β-lactamase reveals that the larger-sized library produced improved hit rates and potency along with an increased number of scaffolds. #ChemBio #chemsky #compchem

www.nature.com/articles/s41...
The impact of library size and scale of testing on virtual screening - Nature Chemical Biology
The docking of a 1.7 billion- versus a 99 million-molecule virtual library against β-lactamase revealed that the larger-sized library produced improved hit rates and potency along with an increased nu...
www.nature.com
January 8, 2025 at 10:04 PM
Reposted by Chris Asquith
Cool paper from Cravatt lab: Chemical tools to expand the ligandable proteome: Diversity-oriented synthesis-based photoreactive stereoprobes: www.cell.com/cell-chemica...
Chemical tools to expand the ligandable proteome: Diversity-oriented synthesis-based photoreactive stereoprobes
Many human proteins lack chemical probes and are even considered undruggable. Ogasawara et al. describe diversity-oriented synthesis-inspired photoreactive small molecules (photo-stereoprobes) and the...
www.cell.com
November 19, 2024 at 2:02 AM